Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods and compositions for use of a chemokine receptor antagonist peptide to treat addiction, substance abuse disorders or symptoms thereof

Methods and compositions for use of a chemokine receptor antagonist peptide to treat addiction, substance abuse disorders or symptoms thereof

US Patent 11510961 · Granted Nov 29, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of an all-D-pentapeptide chemokine antagonist to reduce opioid dose in a per2025
Use of an all-D-pentapeptide chemokine antagonist to reduce opioid dose in a per2025
Methods and compositions for use of a chemokine receptor antagonist peptide to t2025
Therapeutic peptides and vaccines2021
Anti-inflammatory peptides for treating non-alcoholic steatohepatitis (NASH)2020
Use of an all-D-pentapeptide chemokine antagonist to reduce opioid dose in a per2020
Uses of peptides to treat brain injury and disease2019
Modified peptide that reduces pain in peripheral neuropathy2018
Therapeutic peptides and vaccines2018
Method of treating HIV in drug resistant non plasma viral reservoirs with monome2012
Therapeutic peptides and vaccines2010
Peptide pharmaceutical compositions2008